Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2006
10/18/2006CN1849513A Methods and compositions for assaying homocysteine
10/18/2006CN1849512A Process for preparing coated magnetic particles
10/18/2006CN1849401A Method for gene identification signature (GIS) analysis
10/18/2006CN1849400A Polynucleotides and polypeptides of the erythropoietin gene
10/18/2006CN1849399A Blood and urine test
10/18/2006CN1849396A Improved inhibitor nucleic acids
10/18/2006CN1849392A Pyrroloquinoline quinone (PQQ)-dependent glucose dehydrogenase modification having excellent substrate specificity
10/18/2006CN1849391A Nitrilases, nucleic acids encoding them and methods for making and using them
10/18/2006CN1849337A Compositions and methods for treating cancer using IGSF9 and LIV-1
10/18/2006CN1849335A Methods of dissociating nongenotropic from genotropic activity of steroid receptors
10/18/2006CN1849334A Lawsonia intracellularis subunit vaccine
10/18/2006CN1849142A 2'-branched nucleosides and flaviviridae mutation
10/18/2006CN1849131A Treating immunological disorders using agonists of interleukin-21 / interleukin-21 receptor
10/18/2006CN1849064A QTL 'mapping as-you-go'
10/18/2006CN1847848A System and method for processing large number of biological microarrays
10/18/2006CN1847847A Cell mechanical period loading system
10/18/2006CN1847846A Hair detecting method for evaluating health status
10/18/2006CN1847408A Thrombocyte glucoprotein HPA-1 and HPA-2 genotype detecting chip and its use
10/18/2006CN1847407A Method of determining ischemic cerebral apoplexy susceptibility with angiogenesis hormone-1 polymorphism
10/18/2006CN1847406A Medical diagnosis reagent powder and its re-dissolving device and method
10/18/2006CN1847405A Fast detection method and instrument for microbe content in food
10/18/2006CN1847399A Isolated luciferases and the use thereof
10/18/2006CN1847321A Solid phase synthesis process of thiazde orange cyanine dye
10/18/2006CN1847257A Mononucleotide polymorphism related to hypertrophic degree of central muscle of hypertrophic cardiomyopathy and its use
10/18/2006CN1846606A Compound mechanical stress cell loading device for simulated joint cavity
10/18/2006CN1280629C Method of preceeding qualitative and/or quantitative analysis against target substance through controlled slow release of marker system and its device
10/18/2006CN1280429C Process for detecting Enterobacter sakazakii by employing molecular hybridization and enzyme-link coloration technology
10/18/2006CN1280428C Biochip system based on minute particle and its application
10/18/2006CN1280427C Cell model in use for screening out drugs, constructing method and application
10/18/2006CN1280426C Quick and sensitive method of quantifying mycolic acid
10/18/2006CN1280425C Quick detection method of parahemolytic vibrio
10/18/2006CN1280422C Asymmetrical PCR amplification method, dedicated primer and use thereof
10/18/2006CN1280307C Cytotoxin T lymphocyte
10/17/2006USRE39352 Creatine amidinohydrolase, production thereof and use thereof
10/17/2006USRE39350 RNA binding protein and binding site useful for expression of recombinant molecules
10/17/2006US7124068 Crystal structure of a deacetylase and inhibitors thereof
10/17/2006US7124033 Method for identifying matched groups
10/17/2006US7122727 Nucleic acid molecules from wheat encoding an R1-protein, and transgenic plant cells and plants comprising the nucleic acid molecules
10/17/2006US7122715 In vitro method to create circular molecules for use in transformation
10/17/2006US7122659 Assay methods and systems
10/17/2006US7122657 UDP-glucose aglycon-glucosytransferase
10/17/2006US7122652 Isolated polynucleotide encoding a variant human pregnane X receptor (hPXR) polypeptide or fragment; detection and genotyping of hPXR alleles in humans, homozygous as well as heterozygous, alleles of the hPXR gene
10/17/2006US7122650 Comprises nucleotide sequences coding polypeptide which inactivates corticotropin-releasing factor (CRF) for use as to in treatment of anxiety and depression
10/17/2006US7122649 Derivatized oligonucleotides having improved uptake and other properties
10/17/2006US7122648 Isolated nucleic acids; binding to antibody; diagnosis of muscular disorders
10/17/2006US7122647 Preparing solid support comprising immobilized biopolymers for detecting, measuring, separating and/or assaying DNA or proteins in a sample
10/17/2006US7122645 Detection of viable agents
10/17/2006US7122639 Chemokine alpha-2 antibodies
10/17/2006US7122630 Proteins in cell cycle regulation; cell cycle protein binds to SYK kinase
10/17/2006US7122629 For forensic analyses, chromosome tissue/cell/organelle-specific markers, production of expression vectors, screening and diagnosis assays
10/17/2006US7122527 Use of antisense oligonucleotides to inhibit the expression of human Akt-1
10/17/2006US7122516 Preparing protease resistant, bioactive amino acid sequences for use as therapeutic peptides; biodrugs; mimetics
10/17/2006US7122384 Analyzing the identification and the concentration of particular target analytes; biological and chemical assays, receptor binding assay; bioassay of proteins, nucleic acids, peptide nucleic acids, biological cells, microorganisms
10/17/2006US7122383 Qualitative analysis; complexing; determination of emission fluorescence
10/17/2006US7122381 Selective affinity material, preparation thereof by molecular imprinting, and use of the same
10/17/2006US7122373 Human genes and gene expression products V
10/17/2006US7122363 Comprises nucleotide sequences coding cyclic nucleotide phosphodiesterases for treatment of cardiovascular, depressive and vascular disorders; cardiotonic agents; antidepressants; antihypertensives; antithrombotics
10/17/2006US7122362 For diagnosing, treating, or preventing disorders associated with aberrant expression of human phosphodiesterases
10/17/2006US7122361 Compositions employing a novel human kinase
10/17/2006US7122360 Polypeptides, polynucleotides and uses thereof
10/17/2006US7122355 Thermostable DNA-Polymerase (separated or inactivated), exonuclease and a primer which does not elongate at low temperatures; enhanced specificity
10/17/2006US7122344 Production of recombinant human uteroglobin (rhUG) for use as a therapeutic in the treatment of inflammation and fibrotic diseases. The invention provides processes, including bacterial expression and protein purification and scaled
10/17/2006US7122341 Engineering of metabolic control
10/17/2006US7122339 Method for generating diversity
10/17/2006US7122338 Liquefaction; incubation; reduce air bubbles; culture product
10/17/2006US7122337 Method for determining calciotropic activity of a preparation of Padina pavonic algae
10/17/2006US7122335 Compounds and methods to enhance rAAV transduction
10/17/2006US7122334 Providing a smaller swatch of material comprising a piece of material and a stain, wherein the smaller swatch is capable of fitting into a microtiter plate; fixing the stain to the material; applying an enzyme to the swatch; incubating the swatch and enzyme; measuring the degree of removal of stain
10/17/2006US7122333 Method and reagent for visually measuring ATP
10/17/2006US7122326 Central nervous system disorders; psychological disorders
10/17/2006US7122321 Evaluating activity of proteins; obtain protein, incubate with modulators, generate activity spectrum, classify protein
10/17/2006US7122319 Multiplexed immunohistochemical assays using molecular tags
10/17/2006US7122318 measuring integrin expression in platelets of a patient to which the drug (especially a sulfonamide) is administered and determining influence of it on integrin expression in cells other than platelets based on the measured expression amount.
10/17/2006US7122317 Identifying transcription factors for use in modulation of gene expression; high-throughput assay
10/17/2006US7122316 Combining mixture of RNA polymerase and reversible inhibitor of RNA polymerase (reversible inhibitor does not hybridize to a target nucleic acid sequence), with sample suspected to contain target nucleic acid, exposing to amplification
10/17/2006US7122315 Method to identify environmental contamination by detecting enteric viruses
10/17/2006US7122314 Methods for detecting vancomycin-resistant microorganisms and compositions therefor
10/17/2006US7122313 Methods and kits for identifying and quantifying RNAs and DNAs associated with RNA and DNA binding proteins
10/17/2006US7122312 Methods for drug target screening
10/17/2006US7122311 Diagnosing respiratory disorder; obtain cells, monitor expression of marker gene, determine sequence, compare to control, detect polymorphism in polypeptide or nucleotide, presence of polymorphism indicates respiratory disorders
10/17/2006US7122310 Generation of self-assembling sequences; obtain oligonucleotide sequences, denature, incubate with probes, allow hybridization, recover products
10/17/2006US7122309 High throughput screening assay for detecting a DNA sequence
10/17/2006US7122308 Testing a sample from a patient for the presence of the s variant of the 5HTTLPR polymorphism in the 5HTT gene, the presence of which indicates increased susceptibility
10/17/2006US7122307 High throughput biological heart rate monitor that is molecularly determined
10/17/2006US7122306 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
10/17/2006US7122305 Methods and compositions for identifying receptor effectors
10/17/2006US7122304 Methods for the storage and synthesis of nucleic acids using a solid support
10/17/2006US7122303 Arrays comprising background features that provide for a measure of a non-specific binding and methods for using the same
10/17/2006US7122302 Method for determining early HCV seroconversion
10/17/2006US7122301 Using immobilized chemoattractants to monitor cell receptor-ligand interactions; bioassay
10/17/2006US7122196 Compounds and methods for diagnosis of tuberculosis
10/17/2006US7122152 Spatiotemporal and geometric optimization of sensor arrays for detecting analytes fluids
10/17/2006US7122110 electroactive material is sufficiently (electro) positive to allow oxidation to occur at the working electrode under the applied potential and is present in an amount which is insufficient to maintain the flow of electric current through the detector to constitute a valid determination of analyte concent
10/17/2006CA2359659C Method for quality control of an attenuated varicella live vaccine
10/13/2006CA2522413A1 Markers for sudden death in heart failure
10/12/2006WO2006108183A2 Label free biosensors and cells
10/12/2006WO2006108135A2 Laser microdissection and microarray analysis of breast tumors reveal estrogen receptor related genes and pathways
10/12/2006WO2006108087A2 Devices and methods for enrichment and alteration of circulating tumor cells and other particles
10/12/2006WO2006108075A2 Compositions and methods for enhancing drug sensitivity and treating drug resistant infections an diseases
10/12/2006WO2006108051A2 Compositions and methods relating to alzheimer's disease